BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Biodefense
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Lisbon
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:WEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:WET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:WEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:WET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:WEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:WET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20210314T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20211107T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20220313T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20221106T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20230312T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20231105T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211130T130000
DTEND;TZID=America/New_York:20211130T153000
DTSTAMP:20210925T002821Z
CREATED:20210925T002750Z
LAST-MODIFIED:20210925T002821Z
UID:49802-1638277200-1638286200@globalbiodefense.com
SUMMARY:Prevention and Preparedness: Webinar 3
DESCRIPTION:The COVID-19 pandemic has illuminated and exacerbated challenges in caring for people of all ages with serious illness. The response to many of these challenges involved rapid innovation and as such provides valuable lessons learned that will likely significantly alter the field of serious illness care in the post-pandemic era. The Roundtable on Quality Care for People with Serious Illness will host a virtual workshop to provide a neutral venue for stakeholders in serious illness care to consider the lessons learned from the pandemic in order to continually improve care for people with serious illness in the future. \nThe virtual workshop will be held over three webinars in November. \n\n8 Nov  12:00 – 3:00PM: Impact of and Response to the Pandemic: Webinar 1\n18 Nov 12:00 – 3:00PM: Recovery and Resilience: Webinar 2\n30 Nov 1:00 – 3:30PM: Prevention and Preparedness: Webinar 3\n\n\nDescription\n\n\n\nA planning committee of the National Academies of Sciences\, Engineering\, and Medicine will organize and host a 1.5-day public workshop to examine the impact of the COVID-19 pandemic on serious illness care and consider lessons learned and future directions\, with specific focus on health care access\, health equity\, and innovative responses to care in the context of  the pandemic. \nThe workshop will feature invited presentations and panel discussions on topics that may include: \nDelivery of person-centered\, family-oriented care \n\nKey role of palliative care teams during the pandemic\nRole of caregivers and impact on caregivers’ physical\, emotional and mental health\nSpecific learnings from different care models in various care settings (e.g.\, hospital-based palliative care\, care at home\, and in the community)\nUse of telehealth and impact on access to care\n\nClinician-Patient-Family communication and advance care planning \n\nUse of technology to connect family members to patients\nUse of serious illness communication guides to train non-palliative care specialist health care professionals\n\nProfessional education and development \n\nUse of technology support and remote applications to quickly train health care professionals\nCollaboration between palliative care teams and ICU/Emergency Department staff\n\nPolicies and payment systems \n\nTelehealth supported by flexibility in payment\nThe need for better alignment between health care and social care\n\nPublic education and engagement \n\nHow to communicate effectively and engage the public in advance care planning\nAddressing grief/bereavement on large scale in the U.S.\n\nThe planning committee will develop the agenda for the workshop\, select speakers and discussants\, and moderate the discussions. A proceedings of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines. \n\n\nPlease visit NASEM’s Caring for People with Serious Illness during the COVID-19 Pandemic: A Workshop on Lessons Learned and Future Directions site for more information.
URL:https://globalbiodefense.com/event/prevention-and-preparedness-webinar-3/
LOCATION:
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211203
DTEND;VALUE=DATE:20211204
DTSTAMP:20210226T214741Z
CREATED:20210226T214741Z
LAST-MODIFIED:20210226T214741Z
UID:48694-1638489600-1638575999@globalbiodefense.com
SUMMARY:One Health: Integrating Human\, Animal and Environmental Health
DESCRIPTION:A virtual science conference on One Health: Integrating Human\, Animal and Environmental Health will be held 3 December 2021. \nThe One Health movement\, which has come to prominence in the last decade\, advocates greater cross-sectoral collaboration and communication across the human-animal-environment interface. There has been a long-standing recognition that population health is intrinsically linked to both animal and environmental health\, and that issues such as population growth\, changes in climate and land use\, and the movement of animals and people\, have a huge impact on the collective health of our world today. \nPlease visit EMBL’s One Health: Integrating Human\, Animal and Environmental Health page for more information.
URL:https://globalbiodefense.com/event/one-health-integrating-human-animal-and-environmental-health/
LOCATION:
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211208T090000
DTEND;TZID=America/New_York:20211208T103000
DTSTAMP:20240623T192553Z
CREATED:20211005T192345Z
LAST-MODIFIED:20240623T192553Z
UID:50043-1638954000-1638959400@globalbiodefense.com
SUMMARY:Current Concepts in Quantitative Risk Assessment for Skin Sensitization
DESCRIPTION:The NTP Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM) is partnering with the Swiss Centre for Applied Human Toxicology and the Swiss State Secretariat for Economic Affairs to present a webinar series on “Current Concepts in Quantitative Risk Assessment for Skin Sensitization.” \nThe next webinar in the series on December 8 will consider the topics of methods for skin sensitization hazard and potency determination using currently available non-animal test methods\, as well as exposure assessment and quantification. \nThe webinar series is free and open to the public. Those who registered to view the first webinar are automatically registered for the second webinar. \nInformation and a link to register are available at https://ntp.niehs.nih.gov/go/ssqra-web. A video from the first webinar in the series\, which presented an introduction to skin sensitization and contact dermatitis\, will be posted on this page when available. \nRegister for the December 8 webinar: “Methods for hazard and exposure assessment”
URL:https://globalbiodefense.com/event/current-concepts-in-quantitative-risk-assessment-for-skin-sensitization/
LOCATION:
CATEGORIES:Conference,Government Hosted,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211216
DTEND;VALUE=DATE:20211217
DTSTAMP:20211106T220805Z
CREATED:20211106T220727Z
LAST-MODIFIED:20211106T220805Z
UID:50876-1639612800-1639699199@globalbiodefense.com
SUMMARY:National Biodefense Science Board Meeting
DESCRIPTION:The National Biodefense Science Board (NBSB) will meet in public (virtually) on December 16\, 2021\, to provide advice and recommendations to ASPR regarding the development of the 2023-2026 National Health Security Strategy and to discuss other matters of current important for public health emergency preparedness\, response\, and recovery. \n\n\n\nA more detailed agenda will be available on the NBSB meeting website https://www.phe.gov/​nbsb. \n\n\n\nProcedures for Public Participation\n\n\n\nMembers of the public may attend the meeting via a toll-free phone number or Zoom teleconference\, which requires pre-registration. The meeting link to pre-register will be posted on the meeting website https://www.phe.gov/​nbsb. Members of the public may provide written comments or submit questions for consideration by the NBSB at any time via email to NBSB@hhs.gov. \nSource: Federal Register Notice
URL:https://globalbiodefense.com/event/national-biodefense-science-board-meeting/
LOCATION:
CATEGORIES:Government Hosted,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220114T103000
DTEND;TZID=America/New_York:20220114T173000
DTSTAMP:20211111T212345Z
CREATED:20211111T212345Z
LAST-MODIFIED:20211111T212345Z
UID:50933-1642156200-1642181400@globalbiodefense.com
SUMMARY:Lessons Learned from the COVID-19 Pandemic to Improve Diagnosis
DESCRIPTION:The National Academies of Sciences\, Engineering\, and Medicine will convene a virtual workshop on January 14\, 2022 to examine changes to diagnostic paradigms in response to the COVID-19 pandemic and to consider the lessons learned and opportunities for improving diagnosis within the U.S. health care system. \nThe workshop will be accessible to the public via live webcast. Please register online to receive an email with the instructions on how to join this workshop. \nPlanning Committee: \n\nDerek Angus\, (Co-chair)\, University of Pittsburgh\nAndrew Bindman (Co-chair)\, Kaiser Permanente\nAmesh Adalja\, Johns Hopkins Center for Health Security\nSuzanne Bakken\, Columbia University\nMarie-Carmelle Elie\, University of Alabama School of Medicine\nNicole Lurie\, Coalition for Epidemic Preparedness Innovations\nKathryn McDonald\, Johns Hopkins University\nKosali Simon\, Indiana University\nSaul Weingart\, Rhode Island Hospital and Brown University\n\nPlease visit NASEM’s Advancing Diagnostic Excellence: A Workshop Series website for more information. \n 
URL:https://globalbiodefense.com/event/lessons-learned-from-the-covid-19-pandemic-to-improve-diagnosis/
LOCATION:
CATEGORIES:Webinar-Webcast,Workshop
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220209
DTEND;VALUE=DATE:20220211
DTSTAMP:20211111T221529Z
CREATED:20211111T221529Z
LAST-MODIFIED:20211111T221529Z
UID:50938-1644364800-1644537599@globalbiodefense.com
SUMMARY:Animal Welfare Challenges in Research and Education on Wildlife\, Non-Model Animal Species and Biodiversity
DESCRIPTION:The National Academies will host a meeting 9-10 February 2022 to discuss the current understanding of animal welfare challenges in research on wildlife and biologically diverse vertebrate animal species.  \nResearch to advance understanding of the ecology and biology of wildlife species is more important than ever as the world confronts issues ranging from biodiversity loss to the emergence of zoonotic diseases. \nThis workshop will focus on issues associated with the unique welfare challenges of conducting research with biologically diverse vertebrates living in varied habitats\, for which guidance resources on wildlife research sometimes conflict and recommendations outlined in the current version of the Guide for the Care and Use of Laboratory Animals (8th edition) can present challenges. \nThe workshop will include presentations and panel discussions to explore topics and questions\, such as: \n\nUnderstanding the growing needs of\, and building strategies for\, enhancing veterinary and Institutional Animal Care and Use Committee (IACUC) expertise on the health and welfare of wildlife and biologically diverse vertebrate animal species;\nDiscuss resource options for improving the development and evaluation of IACUC protocols on research studies involving wildlife and biologically diverse vertebrate animal species interactions in captive and diverse natural environmental settings;\nDiscussing bioethics associated with fieldwork practices (e.g.\, bleeding\, euthanasia including thoracic compressions for small birds) and unique considerations for wildlife and biologically diverse vertebrate animal species; as well as welfare assessments amidst other considerations such as unique physiological\, behavioral\, environmental\, and/or husbandry needs of wildlife and biologically diverse vertebrate animal species;\nDiscussing federal\, state\, and local regulatory and management challenges associated with research on terrestrial and aquatic wildlife and biologically diverse vertebrate animal species;\nDiscussing opportunities for enhancing collaborations between IACUCs and researchers studying wildlife and biologically diverse vertebrate animal species\, including animal-environment interactions\, anthropogenic effects on environment and animal life\, and the relation between animal\, environmental\, and human health.\nDiscussing strategies\, synergies\, and collaborations within and among the wildlife and biologically diverse vertebrate animal research\, and biodiversity communities that could leverage national level research resources\, identify knowledge gaps\, and facilitate knowledge acquisition and sharing.\nReview the reasons and advantages for IACUC review of research using wildlife and biologically diverse vertebrate animal species\, including regulatory compliance\, public relations\, and institutional protection.\n\nPlease visit NASEM’s Animal Welfare Challenges in Research and Education on Wildlife\, Non-Model Animal Species and Biodiversity website for more information.
URL:https://globalbiodefense.com/event/animal-welfare-challenges-in-research-and-education-on-wildlife-non-model-animal-species-and-biodiversity/
LOCATION:
CATEGORIES:Conference,Webinar-Webcast,Workshop
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220307T133000
DTEND;TZID=America/New_York:20220307T150000
DTSTAMP:20220305T134424Z
CREATED:20220303T133528Z
LAST-MODIFIED:20220305T134424Z
UID:54171-1646659800-1646665200@globalbiodefense.com
SUMMARY:National Biodefense Science Board Public Meeting
DESCRIPTION:The next public meeting of the National Biodefense Science Board (NBSB) will take place Monday\, 7 March 2022 from 1:30pm – 3:00pm ET via Zoom. \nJoin federal leaders\, National Biodefense Science Board members\, distinguished guests\, and other experts to discuss topics related to the public health supply chain and climate change.  NBSB will hear from the HHS Office of Climate Change and Health Equity and Joint Program Executive Office for Chemical\, Biological\, Radiological\, and Nuclear Defense (JPEO-CBRND) during the meeting. \nSubject matter experts from industry; academia; health systems; health consumer organizations; state\, local\, tribal\, and territorial public health; and emergency management agencies will also have an opportunity to provide comments to the NBSB on national priorities for biodefense and health security. Individual remarks will be limited to seven minutes each and the display of images and/or slides for public speakers will not be available. \nRequests to provide remarks to the NBSB during the public meeting must be sent to NBSB@hhs.gov by March 4\, 2022. In that request\, please provide the speaker’s name\, title\, and position with a brief summary of planned comments. The number of speakers and topics will be based on relevance to the mission of the NBSB and amount of time available on the agenda.  Those selected for public comments will receive confirmation by email prior to the meeting date with additional instructions. \nRegistration for this event is required and can be accessed along with additional meeting information through the online event page.  We encourage you to share this engagement information broadly across your network in advance of the meeting. \nMeeting materials will be made available to the public on the National Biodefense Science Board webpage. For any additional information or questions specific to this event\, please contact NBSB@hhs.gov directly.
URL:https://globalbiodefense.com/event/national-biodefense-science-board-public-meeting-3/
LOCATION:https://hhsasproea.zoomgov.com/webinar/register/WN_DdvW3yVpTuGWSIey8ZsfBg
CATEGORIES:Government Hosted,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220322
DTEND;VALUE=DATE:20220325
DTSTAMP:20220225T203340Z
CREATED:20220225T203242Z
LAST-MODIFIED:20220225T203340Z
UID:54067-1647907200-1648166399@globalbiodefense.com
SUMMARY:ASPPH Annual Meeting 2022
DESCRIPTION:The Association of Schools and Programs of Public Health ASPPH Annual Meeting 2022 will be held online 22-24 March 2022. \nThe ASPPH Annual Meeting convenes academic public health leaders\, faculty\, students\, and members of the public health community from around the world for three days to engage in discussions and share new strategies and tools to strengthen education\, practice\, and research in public health. \nHighlighted topics include: \n\nEducation for Public Health in a Post-COVID World\nBuilding Trust in Public Health Emergency Preparedness and Response\nGlobal Governance for Health: The Role of Academic Public Health\nUsing ASPPH Data Resources for Academic Public Health Research\nUnderstanding and Responding to Health Misinformation and Disinformation\nThe Public Health Fulcrum: Convening for Multi-disciplinary and Interprofessional Education for Collaborative Practice\nUsing Digital Marketing for Engagement and Recruitment\nClimate Change and Health: The Defining Issue of Our Time\n\nPlease visit the ASPPH website for more information.
URL:https://globalbiodefense.com/event/aspph-annual-meeting-2022/
LOCATION:https://globalbiodefense.com/event/aspph-annual-meeting-2022/
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220327
DTEND;VALUE=DATE:20220401
DTSTAMP:20220325T155530Z
CREATED:20220225T165130Z
LAST-MODIFIED:20220325T155530Z
UID:54584-1648339200-1648771199@globalbiodefense.com
SUMMARY:SOT 2022 - Society of Toxicology Annual Meeting
DESCRIPTION:The 61st Annual Meeting of the Society of Toxicology will be held 27-31 March 2022 in San Diego\, California with livestream options for remote participation. \nThis year’s meeting will include all the traditional hallmarks—2\,000+ scientific presentations across 70+ sessions; 250 exhibitors with products and services in the ToxExpo; and scores of networking and social events. This year’s meeting will also feature a key new element that will enhance the meeting experience for all. Registrants not traveling to the meeting can watch all the Featured and Scientific Sessions live through the SOT Event App or Online Planner. Of note\, all registrants can access these same sessions through on-demand recordings that will be available in the SOT Event App and Online Planner after their conclusion. These on-demand videos will be viewable to registrants through July 31\, 2022. \nHighlighted sessions of interest include: \n\nConceptual Models in Immunotoxicology: Leveraging Biological Knowledge\, Alternative Approaches\, and Computational Strategies for the Future of Risk Assessment\nAll for One and One for All: One Environmental Health in Toxicology\nMethodological Aspects of Vascular Toxicity\nPrinciples and Applications of Read-Across in Human Health Risk Assessment\nHow Advances in Exposure Science and Toxicology Are Changing Assessments of the Effects of Chemical Mixtures on Human Health\nLeading-Edge Microbiome Methods for Toxicological Applications\nApplications of Single Cell Profiling Methods to Enhance Mechanistic Understanding of Toxicological Responses\nNext-Level Neurotoxicology: New Technologies to Advance Visualization of Spatial Molecular Alterations and Behavioral Phenotyping\nComparative Toxicology\, Pathology\, and Veterinary Specialty Section Officers Meeting\nAssay Gaps in the Developmental Neurotoxicity (DNT) New Approach Methodologies (NAMs) Battery for Human Health Risk Assessment\nApplication of the devTOX quickPredict and Cardio quickPredict Biomarker-Based In Vitro Assays for Toxicity Screening: Presented by Stemina Biomarker Discovery\nBiotechnology\, Mechanisms\, Molecular and Systems Biology Joint Specialty Section Mentoring Event\nSimulated-Use Extractables: A Risk Mitigation Strategy for Medical Device Toxicological Risk Assessments (TRAs): Presented by WuXi AppTec – Laboratory Testing Division\nBad Breath: Noninvasive Investigation into the Exhaled Biomarkers for Toxicological Research\nUp to the Task? Quantitative Evaluation Criteria for Physiologically Based Pharmacokinetic (PBPK) Models\n\nPlease include the following National Toxicology Program (NTP) Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM) and Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) activities in your itinerary for the first two days of the Society of Toxicology (SOT) 2022 annual meeting. A list of all NICEATM and ICCVAM activities is available here. For remote participants\, all times are Pacific Daylight Time. \nSunday\, March 27: Continuing Education Courses: \n\nAM02: Conceptual Models in Immunotoxicology: Leveraging Biological Knowledge\, Alternative Approaches\, and Computational Strategies for the Future of Risk Assessment (8:15 a.m.-12 noon): Acting NICEATM Director Nicole Kleinstreuer is a speaker.\nPM11: Next-Level Neurotoxicology: New Technologies to Advance Visualization of Spatial Molecular Alterations and Behavioral Phenotyping (1:15-5:00 p.m.): NICEATM scientist Helena Hogberg (National Institute of Environmental Health Sciences) is presenting.\n\nMonday\, March 28: Oral Presentation Sessions: \n\nSymposium Session: New Approach Methods for Functional Developmental Neurotoxicity (9:15 a.m.-12:00 noon – CC Ballroom 6E): ICCVAM advisory committee member Tamara Tal (Helmholtz Centre for Environmental Research) is session chair; Acting NICEATM Director Nicole Kleinstreuer is session co-chair.\nPlatform Session: Risk Assessment (9:15 a.m.-12:00 noon – CC Room 8): “Modification of the Skin Allergy Risk Assessment (SARA) Model for GHS Classification and Its Application to Isothiazolinone Case Studies\,” presented by NICEATM scientist Judy Strickland (Inotiv\, contractor supporting NICEATM).\n\nMonday\, March 28: Poster Sessions: \n\nPFAS I (9:00-10:45 a.m.)\nAutoimmunity/Hypersensitivity (2:30-4:15 p.m.)\nNeurotoxicity: General (2:30-4:15 p.m.)\nReproductive and Developmental Toxicology I (2:30-4:15 p.m.)\nFood Safety/Nutrition (2:30-4:15 p.m.)\n\nProof of COVID-19 vaccination is required to participate in the on-site meeting. \nPlease visit the SOT 2022 website to register and for more information. \n 
URL:https://globalbiodefense.com/event/sot-2022-society-of-toxicology-annual-meeting/
LOCATION:San Diego Convention Center\, 111 West Harbor Drive\, San Diego\, CA 92101\, 92101\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220329
DTEND;VALUE=DATE:20220331
DTSTAMP:20220322T155748Z
CREATED:20220322T155748Z
LAST-MODIFIED:20220322T155748Z
UID:54522-1648512000-1648684799@globalbiodefense.com
SUMMARY:Building Public Trust in Public Health Emergency Preparedness and Response (PHEPR) Science
DESCRIPTION:The National Academies’ Planning Committee on Building Public Trust in Public Health Emergency Preparedness and Response (PHEPR) Science will hold a workshop on 29-30 March. \nWorkshop discussants and participants will collaboratively generate actionable strategies and approaches to (re)build and maintain trust across this continuum\, across stakeholders\, across levels of the system (federal\, state\, tribal\, territorial\, and local)\, and across emergency types. Workshop discussants and participants will specifically: \n\nExamine why the topic of public trust (and trustworthiness\, credibility\, confidence in\, among others) is important in PHEPR science and develop a shared understanding of its importance and its relationship to other factors that contribute to social cohesion in public health emergencies.\nExplore key elements of PHEPR science communication and generate actionable communications strategies based on recent experiences.\nGenerate actionable strategies and approaches for building/maintaining trust\, communicating PHEPR science and the scientific process in the face of uncertainty and in response to the recent decline in perceived credibility of federal\, state\, and local agencies.\nExamine the ways in which diverse demographic groups experience PHEPR science differently and generate strategies and approaches for building trust in PHEPR science and the scientific process that is tailored to these varied experiences.\n\nWorkshop Planning Committee members include: \n\nSandra Quinn\, Ph.D.\, M.Ed. (Chair)\, University of Maryland\nDominique Brossard\, Ph.D.\, University of Madison-Wisconsin\nEsther Chernak\, M.D.\, M.P.H.\, FACP\, Drexel University\nKenny Hendrickson\, Ph.D.\, University of the Virgin Islands\nHilary Karasz\, Ph.D.\, M.A.\, Public Health – Seattle and King County\nJennifer Kiger\, M.P.H.\, LSSBB\, Harris County Public Health\nRachael Piltch-Loeb\, Ph.D.\, M.S.P.H.\, Harvard University\nKai Ruggeri\, Ph.D.\, Columbia University\nMonica Schoch-Spana\, Ph.D.\, Johns Hopkins University\nCathy Slemp\, M.D.\, M.P.H.\, Catherine C Slemp\, LLC
URL:https://globalbiodefense.com/event/building-public-trust-in-public-health-emergency-preparedness-and-response-phepr-science/
LOCATION:
CATEGORIES:Conference,Workshop
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220330T130000
DTEND;TZID=America/New_York:20220330T153000
DTSTAMP:20220323T181737Z
CREATED:20220323T163049Z
LAST-MODIFIED:20220323T181737Z
UID:54546-1648645200-1648654200@globalbiodefense.com
SUMMARY:Inaugural Joint Meeting of NACSD and NACIDD
DESCRIPTION:Please join Assistant Secretary for Preparedness and Response Dawn O’Connell along with Assistant Secretary for Aging and Acting Administrator for Community Living Alison Barkoff\, Wednesday\, March 30 from 1:00 p.m. to 3:30 p.m. ET for the inaugural meeting of the National Advisory Committee on Seniors and Disasters (NACSD) and National Advisory Committee on Individuals with Disabilities and Disasters (NACIDD). \nAdvanced registration for this meeting is required and can be accessed\, along with additional meeting information\, through the online event page. \nDuring this joint meeting\, committee members will be sworn into service and begin a national discussion with federal subject matter experts on the challenges\, opportunities\, and priorities in meeting the unique health needs of older adult populations and people with disabilities during and after disasters and public health emergencies. \nThe agenda includes time to hear from the public. The floor will be open to hear as many relevant comments as possible. To learn how to request a speaking time\, please visit our event page. Meeting materials also will be made publicly available through that page. You can send questions about the NACSD to NACSD@hhs.gov and questions about the NACIDD to NACIDD@hhs.gov. \nBackground \nThe National Advisory Committee on Seniors and Disasters (NACSD) and the National Advisory Committee on Individuals With Disabilities and Disasters (NACIDD)\, or Committees\, were established by sections 2811B and 2811C\, respectively\, of the Public Health Service (PHS) Act\, as amended by the Pandemic and All Hazards Preparedness and Advancing Innovation Act (PAHPAIA) of 2019. The Committees are governed by the provisions of the Federal Advisory Committee Act (FACA) and the General Services Administration FACA Final Rule. The Committees evaluate issues and programs and provide findings\, advice\, and recommendations to the Secretary of HHS to support and enhance all-hazards public health and medical preparedness\, response\, and recovery. The NACSD provides focus on the unique needs of older adults\, while the NACIDD focuses on helping HHS meet the needs of people with disabilities (PWD). The Secretary of HHS has formally delegated authority to operate the NACSD and the NACIDD to ASPR. \nFor Further Information:\nDr. Maxine Kellman\, NACSD Designated Federal Official\, 202-260-0447\, NACSD@hhs.gov; Tabinda Burney\, NACIDD Designated Federal Official\, 202-699-1779\, NACIDD@hhs.gov. Office of the Assistant Secretary for Preparedness and Response (ASPR)\, Department of Health and Human Services (HHS)\, Washington\, DC. \nLearn more and register at the ASPR website \n 
URL:https://globalbiodefense.com/event/national-advisory-committee-on-seniors-and-disasters-nacsd-and-national-advisory-committee-on-individuals-with-disabilities-and-disasters-nacidd/
LOCATION:https://hhsasproea.zoomgov.com/webinar/register/WN_qCfSOHCWT4qTywRzWw_3fA
CATEGORIES:Conference,Government Hosted
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2022/03/nacidd-individuals-disabilities-disasters-seniors-disasters-aspr.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220404T110000
DTEND;TZID=America/New_York:20220404T170000
DTSTAMP:20220321T200058Z
CREATED:20220321T200058Z
LAST-MODIFIED:20220321T200058Z
UID:54494-1649070000-1649091600@globalbiodefense.com
SUMMARY:Public Workshop on Use of Population Descriptors in Genomics Research
DESCRIPTION:The second meeting of the Committee on Use of Race\, Ethnicity\, and Ancestry as Population Descriptors in Genomics Research will be held on April 4 and April 7\, 2022. \nAs part of this workshop\, the committee request public comment on the current use of population descriptors such as race\, ethnicity\, ancestry\, etc. in genomics research and how the use of population descriptors could be improved upon in the future. \nThe agenda will be available on the event webpage. \nThe committee requests public comments as part of this workshop. The committee would like to hear from researchers\, advocates\, and any other interested stakeholders on how population descriptors are currently being used effectively in genomics research\, how they could be improved\, and what systems might be used effectively in the future. \nThe committee will invite a few authors representing a sample of the submissions to present their comments at the workshop on April 4th. If you wish to be considered as a speaker at this workshop\, please submit your comment by March 23rd. Authors of submission submitted after March 23rd may also be considered to be speakers at the workshop in the summer. \nClick here to learn more and submit your comment.
URL:https://globalbiodefense.com/event/public-workshop-on-use-of-population-descriptors-in-genomics-research/
LOCATION:https://bit.ly/nasem-genomics
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220404T130000
DTEND;TZID=America/New_York:20220404T140000
DTSTAMP:20220906T194716Z
CREATED:20220327T183107Z
LAST-MODIFIED:20220906T194716Z
UID:54592-1649077200-1649080800@globalbiodefense.com
SUMMARY:Deterring Russia's Biological\, Chemical and Nuclear Threat
DESCRIPTION:Biological\, Chemical\, and Nuclear Weapons: Can the West deter Russia from using them? \nThe National Committee on American Foreign Policy (NCAFP) will the event 4 April 2022 from 1:00 – 2:00 Eastern. \nOn February 27 President Vladimir Putin ordered Russia’s nuclear deterrent forces to be put on high alert\, sending shockwaves through Europe and the international community. As the conflict has drawn on longer than anticipated\, U.S. intelligence officials have warned of Putin’s “back against the wall” escalations. More recently\, on March 11th\, Russian propaganda outlets accused the U.S. of funding and harboring biological weapons facilities in Ukraine. Although these claims are false\, the Kremlin’s misinformation campaign has signaled to Russia-watchers and intelligence officials that Putin is fabricating information and messaging to justify his own intention to authorize chemical\, biological\, or a possible small tactical nuclear weapon. \nHow can the U.S.\, Europe Union\, and Allies brace for a possible Russian chemical or biological weapons attack in Ukraine? Are there lessons the U.S. has learned from the failure to respond to chemical weapons use in Syria in 2013? How might Western countries prevent\, mitigate\, or respond to such an attack? How could NATO\, the U.S.\, and Allies respond while trying to prevent further escalations? \nTo help answer these questions and many more\, please join the Honorable Andy Weber\, Senior Fellow at the Council on Strategic Risks’ and former Assistant Secretary of Defense for Nuclear\, Chemical and Biological Defense Programs\, and Mr. Ankit Panda\, Stanton Senior Fellow in the Nuclear Policy Program at Carnegie Endowment for International Peace. The program will be moderated by Ambassador (ret.) Susan M. Elliott\, President & CEO of the NCAFP. \nPlease visit the NCAFP’s Deterring Russia’s Biological\, Chemical and Nuclear Threat event page to register. \n 
URL:https://globalbiodefense.com/event/deterring-russias-biological-chemical-and-nuclear-threat/
LOCATION:https://us02web.zoom.us/webinar/register/WN_Sco1z-VkS5yuV4Zr-801Vw
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220413T180000
DTEND;TZID=America/New_York:20220413T200000
DTSTAMP:20220323T224400Z
CREATED:20220323T224249Z
LAST-MODIFIED:20220323T224400Z
UID:54559-1649872800-1649880000@globalbiodefense.com
SUMMARY:Schar School Master's and Certificate Open House
DESCRIPTION:The George Mason University (GMU) Schar School of Policy and Government will host a Master’s and Certificate Open House on April 13\, 2022 from 6:00 pm – 8:00 pm in Arlington\, Virginia. \nThe event will provide an overview of available master’s degree programs and highlight GMU’s world-class faculty and research. Admissions and student services staff will be on hand to answer questions. \nThis in-person event is the perfect opportunity to: \n\nExplore our top-ranked master’s degree and graduate certificate programs\nMeet Schar School Dean Mark Rozell\, program directors\, current students\, alumni\, and admissions team\nVisit the Schar School\nLearn about your program of interest in depth\, including the curriculum\, admissions requirements\, and career opportunities\nAsk admissions team members specific questions about the application process\n\nHave your application fee waived  \nProspective master’s and graduate certificate students who attend this event will be provided with an application fee waiver for the Fall 2022 graduate application. \nRegister to attend here. \nGlobal Biodefense is an official media partner of the GMU Schar School Biodefense program.
URL:https://globalbiodefense.com/event/schar-school-masters-and-certificate-open-house/
LOCATION:George Mason University Arlington Campus\, 3351 Fairfax Dr\, Arlington\, VA\, 22201\, United States
CATEGORIES:Workshop
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2022/03/220413-schar-school-open-house-large-banner-event.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220418
DTEND;VALUE=DATE:20220520
DTSTAMP:20220323T164348Z
CREATED:20220323T164348Z
LAST-MODIFIED:20220323T164348Z
UID:54551-1650240000-1653004799@globalbiodefense.com
SUMMARY:ICE\, ICE\, Data: Using NICEATM’s Integrated Chemical Environment to Support Chemical Evaluations
DESCRIPTION:Join us April 18-19 for a special training session featuring experts from the NTP Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM). \nNICEATM’s Integrated Chemical Environment is a free online suite that houses curated toxicity and physicochemical property data\, integrated into a variety of tools to analyze and visualize chemical data. These tools provide data access adhering to FAIR principles: data that is Findable\, Accessible\, Interoperable\, and Reusable for chemical characterization\, PBPK\, IVIVE\, and more! \nAt this two-day event\, you will learn directly from NICEATM developers how to use the Integrated Chemical Environment and have the opportunity to have your questions answered in the Q&A session. For your convenience\, a printable agenda is available for download below. You will receive session materials through the Zoom Webinar platform ahead of the event. Recordings and other materials will be made available shortly after the sessions. Registration is free\, but required to attend.
URL:https://globalbiodefense.com/event/ice-ice-data-using-niceatms-integrated-chemical-environment-to-support-chemical-evaluations/
LOCATION:https://us06web.zoom.us/webinar/register/WN_UK_LklHqT5iGGtBgCy_Cjg
CATEGORIES:Conference,Training
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2022/03/NURA-ICE.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220423
DTEND;VALUE=DATE:20220427
DTSTAMP:20220421T013722Z
CREATED:20220420T234848Z
LAST-MODIFIED:20220421T013722Z
UID:54824-1650672000-1651017599@globalbiodefense.com
SUMMARY:32nd EECMID - European Congress of Clinical Microbiology & Infectious Diseases
DESCRIPTION:The 32nd European Congress of Clinical Microbiology & Infectious Disease (ECCMID) will take place as a hybrid event both online and in Lisbon\, Portugal on 23 – 26 April 2022. \nThe event brings together experts from many fields to present their latest findings\, guidelines and experiences to an audience of over 14\,000 colleagues. This year\, the congress will feature a hybrid format to facilitate an onsite and online experience for attendees allowing for remote and face-to-face opportunities to take part in the multifaceted programme. \nHighlighted programme topics include: \n\nAdvances in Clostridioides difficile infection outbreak prevention and control\nDigging in the molecular epidemiology of MDR Enterobacterales\nNovel insights into herpetic infections\nOpportunistic infections of the central nervous system\nFungal infections from head to toes\nPathogenic Escherichia coli: the emergence of cross pathotypes from the genomic continuum\nOne Health and mycology: what are the significant and potential interactions between agriculture and human health?\nLeveraging the host response to acute infection to create new diagnostic and prognostic tools\nNew insights into phages: current challenges and future developments\nHow to apply Digital PCR in clinical microbiology\nmRNA science: a paradigm shift to address unmet medical needs\nA post-COVID syndrome: a never-ending story\nPathogens and the microbiome: antibiotics at the crossroads\nRespiratory viral infections in hospital settings\nRole of monoclonal antibodies (mAbs) in the evolution of COVID-19 treatment\nNew perspectives on Schistosomiasis in Europe\nShould you manage bloodstream infection differently in immunocompromised patients?\nGenomics underpin the clinical and public health management of tuberculosis\nCOVID-19 diagnostics: new and newer\nNovel predictive and diagnostic tools in severe viral and bacterial infections\nModelling host-pathogen interaction in persistent infections\nRapid diagnostic tools inform prudent antibiotic use\n\nPlease visit the European Congress of Clinical Microbiology & Infectious Diseases 2022 meeting page to register.
URL:https://globalbiodefense.com/event/32nd-eecmid-european-congress-of-clinical-microbiology-infectious-diseases/
LOCATION:Congrex Switzerland\, Reinacherstrasse 131\, Basel\, CH-4053\, Switzerland
CATEGORIES:Conference
ORGANIZER;CN="European Society of Clinical Microbiology and Infectious Diseases (ESCMID)":MAILTO:info@escmid.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220425T070000
DTEND;TZID=America/New_York:20220425T163000
DTSTAMP:20220422T174133Z
CREATED:20220422T174133Z
LAST-MODIFIED:20220422T174133Z
UID:54835-1650870000-1650904200@globalbiodefense.com
SUMMARY:Malaria in Africa: Translating Science Into Practice
DESCRIPTION:The Johns Hopkins Malaria Research Institute will host a World Malaria Day Symposium on 25 April 2022 featuring presentations by the five NIH International Centers of Excellence for Malaria Research (ICEMRs) that are actively working in Africa in the countries of Mali\, Uganda\, Ethiopia\, Kenya\, Malawi\, Mozambique\, Democratic Republic of Congo\, Zimbabwe\, and Zambia. \nCONFIRMED KEYNOTE SPEAKERS \n\nDr. Matshidiso Rebecca Moeti\, Regional Director for Africa\, World Health Organization\n“Science\, research and precision disease control with malaria as entry point”\nDr. Rick Steketee\, Deputy U.S. Global Malaria Coordinator\, U.S. President’s Malaria Initiative\n“Malaria science and program: challenging topics of climate and localization”\nProfessor Sheila Tlou\, ALMA Special Ambassador\, African Leaders Malaria Alliance\n“ALMAs 4-point agenda in the fight against malaria: linking policy\, accountability and action to science”\n\nThe Johns Hopkins Malaria Research Institute’s state-of-the-art facility is the hub for a community of multidisciplinary researchers dedicated to treat\, control and eradicate this deadly disease. Focused on four major areas of research: Entomology\, Parasitology\, Epidemiology and Immunology\, JHMRI boasts experts from around the globe\, all working to prevent and cure malaria. \nPlease visit the Johns Hopkins Malaria Research Institute World Malaria Day Symposium event page to register for the event
URL:https://globalbiodefense.com/event/malaria-in-africa-translating-science-into-practice/
LOCATION:https://jh.zoom.us/webinar/register/WN_KEnjPeZNT8OkDXaSNvYniA
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2022/04/world-malaria-day-johns-hopkins.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220501
DTEND;VALUE=DATE:20220505
DTSTAMP:20220420T225637Z
CREATED:20210925T162254Z
LAST-MODIFIED:20220420T225637Z
UID:49837-1651363200-1651708799@globalbiodefense.com
SUMMARY:2022 ASM Clinical Virology Symposium
DESCRIPTION:The 2022 ASM Clinical Virology Symposium will be held 1-4 May 2022 in West Palm Beach\, Florida and with virtual participation options. \nThe event brings together top biomedical scientists\, physicians and laboratorians to discuss the latest in diagnostic virology\, vaccine development\, molecular diagnostics and more. \nASM will also include a virtual component providing access to the scientific program and accommodating those who are unable or do not wish to attend in-person. Get details on the digital experience. \nThe symposium is intended for physicians\, laboratory directors\, laboratory professionals\, technicians\, laboratory supervisors\, technologists and other health care professionals with an interest in the latest developments in clinical and diagnostic virology. \nHighlighted session topics include: \n\nMeasles Resurgence in the U.S. and Beyond\nHumoral and Cellular Immune Responses to SARS-CoV-2 After Natural Infection and Vaccination\nOpportunities and Challenges for Next Generation Sequencing of SARS-CoV-2\nLaboratory Stewardship of Diagnostic Tests within the Clinical Virology Laboratory\nTesting Trends and Guidelines for Screening and Monitoring of HIV Infections\nCRISPR/Cas Gene Editing as a Strategy for Antiviral Therapy: A Potential Cure for HIV-1\nA Physician’s Perspective on the Clinical Utility of Next Generation Sequencing\nCapacity Building Strategies in Dealing with a Global Outbreak of Viral Disease\nOutcome Studies to Evaluate the Clinical Impact of Laboratory Testing\nAssociation Between Enteroviruses and Acute Flaccid Myelitis\nGlobal Challenge of Emerging & Reemerging Viral Infections – A Report from the Tropics\nInfluenza During the COVID-19 Pandemic\nWastewater-based Epidemiology: Public Health Value of Tracking Existing and Emerging Viruses\nThe Quest for a Safe and Effective RSV Vaccine: Is It Nearly Within Reach?\nAn Update on Standardization and Harmonization of Molecular Diagnostics\n\nPlease visit the ASM Clinical Virology Symposium site for more information.
URL:https://globalbiodefense.com/event/2022-asm-clinical-virology-symposium/
LOCATION:VA
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220503
DTEND;VALUE=DATE:20220507
DTSTAMP:20220420T214323Z
CREATED:20220420T213804Z
LAST-MODIFIED:20220420T214323Z
UID:54802-1651536000-1651881599@globalbiodefense.com
SUMMARY:ABSA 2nd Biosecurity Symposium
DESCRIPTION:ABSA International will host the 2nd Biosecurity Hybrid Symposium 3-6 May 2022 in a hybrid virtual and in-person format in Minneapolis\, Minnesota. \nThe hybrid symposium will consist of papers\, presentations\, keynotes\, posters\, valuable networking opportunities\, and in-person exhibits. Attendees may register for the in-person event or the virtual event. \nThe event will gather biosecurity professionals from a wide range of disciplines with varying expertise to share their experiences and knowledge and to learn from each other. The agenda includes themes on biosecurity governance\, implementation\, personnel reliability\, bioeconomy\, biosecurity in DIYbio communities\, biosecurity training\, cyberbiosecurity\, and interactive discussions on lessons learned and public engagement for the future. \nThe symposium will showcase thought-provoking leaders and pioneering researchers from various traditional and non-traditional fields that intersect with biosecurity. A segment on new and emerging topics in biosecurity will also be featured. \nHighlighted sessions include: \n\nBiosecurity: Past\, Present\, and Future: Vibeke Halkjaer-Knudsen\, PhD\, Sandia National Laboratories\, Albuquerque\, NM\nEnhancing Security for Emerging Biotechnologies through Collaboratively Designed Exercises: Julie E. Fischer\, PhD\, CRDF Global\, Arlington\, VA\nPreventing Future Pandemics: The Critical Role of Biosecurity in Global Health Security: Samantha Dittrich\, PhD\, Merrick & Company\, Arlington\, VA\nEnhancing Biosecurity Globally Through Implementation of Personal Reliability Programs: Brittany Linkous\, MS\, Merrick & Company\, Arlington\, VA\nBiosecurity and the Bioeconomy: J. Bradley Dickerson\, PhD\, Sandia National Laboratories\, Albuquerque\, NM\nLab Design Matters: Maria Landron\, DrPH\, Association of Public Health Laboratories (APHL)\, Silver Spring\, MD\nTianjin Biosecurity Guidelines for Codes of Conduct for Scientists: Gigi Kwik Gronvall\, PhD\, Johns Hopkins Center for Health Security\, Baltimore\, MD\nConcentric by Ginkgo: Building a Biosecurity and Public Health Platform for the Present and Future: Brian Renda\, PhD\, Ginkgo Bioworks\, Boston\, MA\nRegional Legal Framework as a Basis and an Enhancer of Biosafety and Biosecurity in the African Union Member States: Jaures Arnaud Noumedem Kenfack\, Africa Centers for Diseases Control and Prevention\, Abuja\, Nigeria\nInfectious Disease as a Security Threat and the Role of Public Health Emergency Management in Biodefense and Biosecurity: A COVID-19 Case Study: Ryan S. Houser\, MS\, MPH\, Tetra Tech\, Parsippany\, NJ\nBiosecurity Capacity Building Through a Biosecurity Champions Fellowship Program in Pakistan: Samreen Sarwar\, M.Phil\, Health Security Partners\, Lahore\, Pakistan\nIdentifying and Avoiding Common Mistakes in Risk and Threat Management: Lauren Richardson\, DVM\, MPH\, Merrick and Company\, Arlington\, VA\nBeyond Training: Using Behavioral Science to Motivate Proactive Biorisk Management: Daniel Greene\, PhD\, Stanford University\, Stanford\, CA\nCommunity Driven Genome Engineering Biosecurity Workshop: Industry Practices\, Resources\, and Opportunities: Beth Vitalis\, Inscripta\, Boulder\, CO\n\nPlease visit ABSA International’s 2nd Biosecurity Symposium website to register.
URL:https://globalbiodefense.com/event/absa-2nd-biosecurity-symposium/
LOCATION:Renaissanc Minneapolis Hotel\, The Depot\, 225 3rd Ave S\, Minneapolis\, MN\, 55401-2524\, United States
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220503T140000
DTEND;TZID=America/New_York:20220503T150000
DTSTAMP:20220420T201056Z
CREATED:20220420T200824Z
LAST-MODIFIED:20220420T201056Z
UID:54789-1651586400-1651590000@globalbiodefense.com
SUMMARY:COVID-19 Testing Toolkit Webinar: University Testing Strategies
DESCRIPTION:Join the Johns Hopkins Center for Health Security’s COVID-19 Testing Toolkit for a webinar where panelists will discuss how Johns Hopkins University developed and implemented its COVID-19 testing strategies for faculty\, staff\, and students \nMODERATOR \nGigi Gronvall\, PhD\, Senior Scholar\, Johns Hopkins Center for Health Security; Lead\, COVID-19 Testing Toolkit and Associate Professor in the Department of Environmental Health and Engineering at the Johns Hopkins Bloomberg School of Public Health \nPANELISTS \nStephen Gange\, PhD\, Professor of Epidemiology in the Johns Hopkins Bloomberg School of Public Health with a joint appointment in the School of Medicine\, and Executive Vice Provost for Academic Affairs\, Johns Hopkins University \nJonathan Links\, PhD\, Professor of Environmental Health and Engineering in the Johns Hopkins Bloomberg School of Public Health \, with joint professorial appointments in the schools of Medicine\, Education\, Engineering\, and Business\, and Vice Provost and Chief Risk Officer\, Johns Hopkins University \nLainie Rutkow\, JD\, PhD\, Professor of Health Policy and Management in the Johns Hopkins Bloomberg School of Public Health with a joint appointment in the School of Medicine\, and Vice Provost for Interdisciplinary Initiatives\, Johns Hopkins University. \nThe moderated discussion will be followed by a Q&A session. Media are invited. \nLearn more about this event and register HERE.
URL:https://globalbiodefense.com/event/covid-19-testing-toolkit-webinar-university-testing-strategies/
LOCATION:https://jh.zoom.us/webinar/register/WN_I19cGA6FSNWGPHt_6xaYCA
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220504T120000
DTEND;TZID=America/New_York:20220504T133000
DTSTAMP:20220422T200622Z
CREATED:20220422T195642Z
LAST-MODIFIED:20220422T200622Z
UID:54839-1651665600-1651671000@globalbiodefense.com
SUMMARY:Biological Risks and Hazards in the World Today - Special Focus on Russia and Ukraine
DESCRIPTION:An expert panel on Biological Risks and Hazards in the World Today with a Special Focus on Russia and Ukraine will be held on 4 May 2022 via webcast. \nTopics will include the health security environment in the post-Soviet states\, as assessed by the Global Health Security Index of 2019 and 2021\, and the biological risks posed by Russia’s invasion of Ukraine and associated disinformation campaign. \nJessica Bell and Hayley Secerance\, of the Nuclear Threat Initiative\, will discuss health security environment across the post-Soviet states. \nGregory Koblentz of George Mason University will address the evolving biosecurity landscape. \nHon. Andrew Weber of the Council on Strategic Risks and former Assistant Secretary of Defense for the Obama Administration will discuss what we know and what we don’t know about the Russian Federation’s biological and chemical weapons’ program. \nRebecca Katz of Georgetown University and Ian Lipkin of Columbia University round out the event. \nThe webinar will be moderated by Wilmot James. \nPlease visit the Columbia University Institute for Social and Economic Research and Policy (ISERP) Biological Risks and Hazards in the World Today event page to register.
URL:https://globalbiodefense.com/event/iserp-biological-risk-hazards-russia-ukraine/
LOCATION:https://columbiauniversity.zoom.us/webinar/register/WN_EalzNo1oQw6zWvNG-iWjvA
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220510
DTEND;VALUE=DATE:20220512
DTSTAMP:20220325T162045Z
CREATED:20220325T162045Z
LAST-MODIFIED:20220325T162045Z
UID:54586-1652140800-1652313599@globalbiodefense.com
SUMMARY:FutureTox V: New Technologies to Evaluate Organ-Specific Effects of Drugs and Chemicals
DESCRIPTION:The Society of Toxicology will host FutureTox V: New Technologies to Evaluate Organ-Specific Effects of Drugs and Chemicals on 10-11 May 2022 in Chapel Hill\, North Carolina. \nThe FutureTox series focuses on building the road for 21st-century toxicology and risk assessment practices\, utilizing in vitro data and in silico models for predictive toxicology\, and taking the high-throughput risk assessment paradigm forward to address challenges in implementing the emerging big-data toolbox for risk assessment and regulatory decision-making. \nHighlighted topics of interest include: \n\nModeling environment for organ-specific computational synthesis and integration\nNovel single cell sequencing-based technologies\nIn silico models of organ-specific effects\nFDA\, EPA discussion on future tech and research needs to evaluate organ-specific effects of drugs and chemicals\nFDA\, EPA discussion on opportunities for regulators to use new models and technologies in evaluating organ-specific effects of drugs and chemicals\nNIEHS/NICEATM\, EPA breakout discussion of ‘big data’ stream utilization in toxicology and risk assessment\nAdvantages and barriers to application of new models for evaluating effects of drugs and chemicals on the blood-brain barrier\nPerfused microphysiological systems\nLiver spheroids and micropatterned cultures\nModeling the gut microbiome\nAir-liquid interface models for airway safety assessment\nOpportunities to advance IVIVE with physiological organ-specific models\n\nPlease visit the Society of Toxicology’s FutureTox V website for more information. \n 
URL:https://globalbiodefense.com/event/futuretox-v-new-technologies-to-evaluate-organ-specific-effects-of-drugs-and-chemicals/
LOCATION:UNC Chapel Hill Friday Center\, 100 Friday Center Drive\, Chapel Hill\, NC\, 27599\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220517
DTEND;VALUE=DATE:20220519
DTSTAMP:20220422T205702Z
CREATED:20220422T205336Z
LAST-MODIFIED:20220422T205702Z
UID:54847-1652745600-1652918399@globalbiodefense.com
SUMMARY:What Happened to the Plans? Lessons Observed from COVID-19 - A Workshop
DESCRIPTION:A planning committee of the National Academies of Sciences\, Engineering\, and Medicine will organize and convene a day and half public health workshop. During this workshop\, invited participants from government\, NGO\, and private sector organizations will explore the nation’s Public Health Emergency (PHE) preparedness enterprise\, including existing PHE preparedness and response plans\, systems\, and structures\, through the lens the COVID-19 response in the United States. \nThe activity will explore key components\, success stories\, as well as failure points throughout the entire PHE preparedness and response enterprise in order to identify opportunities for more effective catastrophic disaster\, pandemic\, and other large scale PHEs planning at the federal\, state\, local\, tribal\, and territorial levels. Using key components of past NASEM reports to frame workshop discussions\, participants will examine specific lessons learned from the COVID-19 pandemic and explore potential paths forward. Specifically\, the workshop will examine: \nWeaknesses and opportunities in the PHE’s systems architecture\, including but not limited to \n\nGlobal disease surveillance;\nHealthcare delivery and core public health functions;\nSupply chain viability and vulnerabilities;\nMedical Counter Measure (MCM) development\, distribution & administration/delivery;\nData systems and other promising opportunities for preparedness and response technology platforms etc.\n\nThe continuum of local-state-regional-national coordination challenges and leadership incident command structure disparities\, including: \n\nPreparedness and response capabilities\, authorities\, and funding streams;\nStaffing challenges and potentially strength of community partnerships to assist in preparedness\, community organizing and vaccine advocacy; and\nRisk communication and messaging failures.\n\nThe planning committee will define the specific topics to be addressed\, develop the agendas\, and select and invite speakers and other participants. After the workshop\, a proceedings-in-brief will be prepared. \nPlease visit the National Academies’ What Happened to the Plans? Lessons Observed from COVID-19 and the Future of the Public Health Emergency Enterprise – A Workshop webpage for more information.
URL:https://globalbiodefense.com/event/what-happened-to-the-plans-lessons-observed-from-covid-19-a-workshop/
LOCATION:National Academies of Sciences\, 2101 Constitution Ave NW\, Washington\, DC\, 20418\, United States
CATEGORIES:Webinar-Webcast,Workshop
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20220524T130000
DTEND;TZID=America/Los_Angeles:20220524T140000
DTSTAMP:20220420T223007Z
CREATED:20220420T223007Z
LAST-MODIFIED:20220420T223007Z
UID:54810-1653397200-1653400800@globalbiodefense.com
SUMMARY:Disease\, Diplomacy and Displacement: Syrian Refugees and the Politics of Health in Jordan
DESCRIPTION:Stanford University’s Center for International Security and Cooperation (CISAC) will host a lecture event on Disease\, Diplomacy and Displacement: Syrian Refugees and the Politics of Health in Jordan on 24 May 2022. \nThe event is open to the public through a virtual option. Those with an active Stanford ID may attend in person at Encina Hall. \nAbout the Speaker: \nSigrid Lupieri is a postdoctoral at the Center for International Security and Cooperation. Dr.Lupieri received her Ph.D. from the Center of Development Studies at the University of Cambridge. She also holds an MPhil in Modern European History from the University of Cambridge and an M.S. in Journalism from Northwestern University. Her primary research investigates how security concerns\, foreign policy agendas\, and diplomacy shape the priorities of refugee responses. In her current book project\, based on the case study of the Syrian refugee crisis in the Middle East\, she finds that security and diplomatic interests have wide-ranging effects on humanitarian health spending\, including a disproportionate focus on infectious diseases and the inequitable distribution of resources. In other research\, Dr. Lupieri explores the impact of refugee movements on the healthcare systems of host countries\, and the intended and unintended effects of international aid on refugee welfare. Outside of academia\, she has worked for several years as a journalist in Armenia\, Georgia\, and Germany\, and as a UN officer in New York and New Delhi. the Senior Director and Lead Scientist\, Global Biological Policy and Programs at NTI. \nPlease visit CISAC’s Disease\, Diplomacy and Displacement: Syrian Refugees and the Politics of Health in Jordan event listing to register.
URL:https://globalbiodefense.com/event/disease-diplomacy-and-displacement-syrian-refugees-and-the-politics-of-health-in-jordan/
LOCATION:Encina Hall\, 616 Jane Stanford Way\, Stanford\, CA\, 94305-6055\, United States
CATEGORIES:Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220602T132000
DTEND;TZID=America/New_York:20220602T154500
DTSTAMP:20220601T173444Z
CREATED:20220601T173444Z
LAST-MODIFIED:20220601T173444Z
UID:55587-1654176000-1654184700@globalbiodefense.com
SUMMARY:Future Trends in the Bioeconomy and Changing Life Sciences Research Landscape
DESCRIPTION:The National Academies’ Board on Life Sciences is pleased to present two discussions – Bioeconomy of the Future and Changing Landscape of Life Science Research Laboratories – to explore critical and emerging issues with the bioeconomy and privately-sponsored basic life sciences research. \nThe life sciences research landscape is changing rapidly as new investments in the bioeconomy drive convergence among science and technology fields to develop new products and services\, and as basic research laboratories are established by private investors. \nThe Bioeconomy of the Future will explore: \n\nChanges that have taken place since publication of the National Bioeconomy Blueprint (2012)\, Safeguarding the Bioeconomy (2020)\, and The Bio Revolution: Innovations Transforming Economies\, Societies\, and our Lives (2020)\nImmediate and near-term developments associated with the bioeconomy\nFuture needs for realizing the full potential of the bioeconomy\nOutstanding needs for protecting and promoting the bioeconomy long-term\n\nFeatured Speakers \n\nMary Maxon\, Schmidt Futures\nAndrea Hodgson\, Schmidt Futures\nMichael Chui\, McKinsey & Company\n\nThe Changing Landscape of Life Sciences Research Laboratories will explore: \n\nShifts in the landscape of life sciences research based on the emergence of research institutes funded by for-profit companies\nThe benefits to the shifting life sciences research landscape\nPossible trade-offs related to life sciences research that are conducted at for-profit institutions\nEmerging trends in life science research landscape and how they relate to current and future public policy\nFuture workforce needs and how education might change to support these new institutions\n\nPlease visit the National Academies’ Future Trends in the Bioeconomy and Changing Life Sciences Research Landscape event page for more information.
URL:https://globalbiodefense.com/event/future-trends-in-the-bioeconomy-and-changing-life-sciences-research-landscape/
LOCATION:https://www.nationalacademies.org/event/06-02-2022/board-on-life-sciences-open-webinar-future-trends-in-the-bioeconomy-and-changing-life-sciences-research-landscape
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220608T180000
DTEND;TZID=America/New_York:20220608T180000
DTSTAMP:20220527T184920Z
CREATED:20220527T184920Z
LAST-MODIFIED:20220527T184920Z
UID:55106-1654711200-1654711200@globalbiodefense.com
SUMMARY:GMU Schar School of Policy and Government Virtual Open House
DESCRIPTION:The George Mason University (GMU) Schar School of Policy and Government will host a Master’s and Certificate Virtual Open House on June 8\, 2022 from 6:00 pm – 8:00 pm. \nThe event will provide an overview of available master’s degree programs and highlight GMU’s world-class faculty and research. Admissions and student services staff will be on hand to answer questions. \nThis event is the perfect opportunity to: \n\nExplore Schar School’s top-ranked master’s degree and graduate certificate programs\nLearn about your program of interest in depth\, including the curriculum\, admissions requirements\, and career opportunities\nAsk admissions team members specific questions about the application process\n\nBreakout sessions hosted by program directors and faculty will be available based on your primary program of interest: \nMaster’s in Biodefense\nMaster’s in International Commerce and Policy\nMaster’s in International Security\nMaster’s in Organization Development and Knowledge Management\nMaster’s in Political Science\nMaster’s in Public Administration (MPA)\nMaster’s in Public Policy (MPP) \nBiodefense Certificate\nEmergency Management and Homeland Security Certificate\nGlobal Health and Security Certificate\nIllicit Trade Analysis Certificate\nNational Security and Public Policy Certificate\nNonprofit Management Certificate\nPublic Management Certificate\nScience\, Technology\, and Security Certificate\nStrategic Trade Certificate\nTerrorism and Homeland Security Certificate \nFind more information and register to attend here. \nGlobal Biodefense is an official media partner of the GMU Schar School Biodefense program.
URL:https://globalbiodefense.com/event/gmu-schar-school-of-policy-and-government-virtual-open-house/
LOCATION:
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2022/05/schar-school-open-house-june-2022.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220609
DTEND;VALUE=DATE:20220614
DTSTAMP:20240623T192335Z
CREATED:20210925T163351Z
LAST-MODIFIED:20240623T192335Z
UID:49843-1654732800-1655164799@globalbiodefense.com
SUMMARY:ASM Microbe 2022
DESCRIPTION:ASM Microbe 2022 will be held 9-13 June 2022 in Washington\, D.C. \nASM Microbe 2022 will also include a virtual component providing access to scientific programming and accommodating those who are unable or do not wish to attend in-person. Get details on the digital experience. \nAntimicrobial agents and resistance\, biofilms\, HAIs\, diagnostic immunology\, antifungal agents\, and pharmacological studies of antimicrobial agents are just some of the core topics covered in this can’t-miss event. \nHighlighted sessions and topics include: \n\nNGS for Near Real-Time Surveillance and Outbreak Response by Public Health and Clinical Labs\nPublic Health Implications of Fungal Diseases: It’s Time for Action\nUse of Human Organ-on-Chip and Organoid Platforms in Acute Viral Disease\nIn-depth Symposium. AAR14M. One Health Right Now\nTick\, Talk\, Boom: Newly Emerging Tick-Transmitted Disease\nPre-Term and Pediatric Infections: How to Prevent and How to Treat\nCrossing the Threshold: Pros and Cons of Reporting Cycle Threshold Values\nWastewater-based Epidemiology: SARS-CoV-2 and Other Emerging Pathogens\nFungi Enter the AMR Arena\nUsing Protein Structure Prediction Algorithms\nThe Pre-clinical Antimicrobial Pipeline: What is Really New?\nHistopathology of Infectious Diseases for Clinical Microbiologists\nParasites\, Global Health and Novel Pathogens: My Journey as a Clinical Microbiologist\nUpdate on Rapid Diagnostics in Infectious Diseases\nAvoiding Dogmas and Pitfalls in Clinical Parasitology\nAdaptation of Mouse Models for Human Adapted Pathogens\nCurrent Status of Vaccine Research and Development for Clostridioides difficile\nLaboratory diagnostics for invasive fungal infections with a focus on immunocompromised hosts\nI Can’t Take This Anymore–Taxonomic Changes in Microbiology (Can We Find Common Ground?)\nOld Foes\, New Horizons: Updates and Innovations in Malaria and Polio Vaccines\nScience Communication: Combating Vaccine Hesitancy\nChallenging Gram-positive Clinical Cases for Application of New Agents\nMicrobiology in Space: Moving Beyond Low Earth Orbit to the Moon and Mars\nVerification and Validation of Microbiology Tests: Tackling the Who\, What\, When\, Why and HOW?\nBacterial Integration of Host Microbiota Cues Regulate Fitness and Virulence\nThe Pandemic Response in Developing Nations: TB Re-emergence and Other Unexpected Challenge\nDrug Resistance and Diarrheal Disease in the Developing World\nPlastics\, Metals and Other Contaminants as AMR Hotspots and Transporters\nPathogens and Pest Control in Agriculture\nMicrobiomes of Livestock in Food Systems: Emerging Pathogens\, Probiotics and Alternatives to Antibiotics\nNew Agents Discovery Summary Session: Early New Antimicrobial Agents\nMicrobiology and Stewardship Lessons Learned During the COVID-19 Pandemic\n\n Please visit the ASM Microbe website for more information.
URL:https://globalbiodefense.com/event/asm-microbe-2022/
LOCATION:Washington DC Area\, Washington\, DC\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220614T083000
DTEND;TZID=America/New_York:20220614T170000
DTSTAMP:20220527T205853Z
CREATED:20220527T205356Z
LAST-MODIFIED:20220527T205853Z
UID:55113-1655195400-1655226000@globalbiodefense.com
SUMMARY:VRBPAC Meeting to Review Moderna Pediatric (Ages 6-17) mRNA Vaccine EAU
DESCRIPTION:The VRBPAC committee will meet in open session on June 14\, 2022 to discuss amending the EUA of the Moderna COVID-19 mRNA vaccine to include the administration of the primary series to children and adolescents 6 years through 17 years of age. \nFDA intends to make background material available to the public no later than 2 business days before the meeting.  If FDA is unable to post the background material on its website prior to the meeting\, any background material will be made publicly available at the time of the advisory committee meeting\, and additional materials will be posted on FDA’s website after the meeting. \nMaterials for this meeting will be available at the Vaccines and Related Biological Products Advisory Committee meetings main page. \nInterested persons may present data\, information\, or views\, orally or in writing\, on issues pending before the committee. FDA is establishing a docket for public comment on this meeting. The Docket Number is FDA-2022-N-0904 \nOn June 15\, 2022\, under Topic II\, the committee will meet in open session to discuss amending the EUA of the Moderna COVID-19 mRNA vaccine to include the administration of the primary series to infants and children 6 months through 5 years of age\, and also to discuss amending the EUA of the Pfizer-BioNTech COVID-19 mRNA vaccine to include the administration of the primary series to infants and children 6 months through 4 years of age. \n  \n  \n 
URL:https://globalbiodefense.com/event/vrbpac-meeting-to-review-moderna-pediatric-ages-6-17-mrna-vaccine-eau/
LOCATION:https://www.youtube.com/watch?v=GbNpaZeDPiA
CATEGORIES:Government Hosted,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220615T083000
DTEND;TZID=America/New_York:20220615T170000
DTSTAMP:20220527T210409Z
CREATED:20220527T210409Z
LAST-MODIFIED:20220527T210409Z
UID:55115-1655281800-1655312400@globalbiodefense.com
SUMMARY:VRBPAC Meeting to Review Pediatric (Infant - 5 Years) mRNA Vaccines
DESCRIPTION:The VRBPAC will meet in open session to discuss amending the EUA of the Moderna COVID-19 mRNA vaccine to include the administration of the primary series to infants and children 6 months through 5 years of age\, and also to discuss amending the EUA of the Pfizer-BioNTech COVID-19 mRNA vaccine to include the administration of the primary series to infants and children 6 months through 4 years of age. \nFDA intends to make background material available to the public no later than 2 business days before the meeting.  If FDA is unable to post the background material on its website prior to the meeting\, any background material will be made publicly available at the time of the advisory committee meeting\, and additional materials will be posted on FDA’s website after the meeting. \nMaterials for this meeting will be available at the Vaccines and Related Biological Products Advisory Committee meetings main page. \nInterested persons may present data\, information\, or views\, orally or in writing\, on issues pending before the committee. FDA is establishing a docket for public comment on this meeting. The Docket Number is FDA-2022-N-0904.
URL:https://globalbiodefense.com/event/vrbpac-meeting-to-review-pediatric-infant-5-years-mrna-vaccines/
LOCATION:https://www.youtube.com/watch?v=Ixm4UmldTGQ
CATEGORIES:Government Hosted,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220619
DTEND;VALUE=DATE:20220624
DTSTAMP:20210226T210720Z
CREATED:20210226T210720Z
LAST-MODIFIED:20210226T210720Z
UID:48681-1655596800-1656028799@globalbiodefense.com
SUMMARY:ISPPD-12 International Symposium on Pneumococci and Pneumococcal Diseases
DESCRIPTION:Discover the latest achievements in the fight against the pneumococcus at the ISPPD-12 International Symposium on Pneumococci and Pneumococcal Diseases 19-23 June 2022 in Toronto. \nThis meeting was originally scheduled for Oct 2020. Given on-going safety concerns for in-person meetings due to COVID-19 during 2020-2021\, the in-person event was ultimately pushed to June 2022. \nThe event brings together professionals in the field to raise global awareness and improve standards of diagnosis\, prevention and treatment. \nHighlighted topics include: \n\nEpidemics\, outbreaks\, and special settings\nPneumococcal epidemiology\nVaccine effect on disease in children\nTrends in non-vaccine serotypes\nMathematical modeling\nDiagnosis and diagnostic assays\nAntimicrobial resistance\nConventional and molecular microbiology\nTreatment of pneumonia and pneumococcal disease\nGenetic sequencing\nPneumococcal colonization\nAdult vaccination strategies\nIndirect effects of paediatric programmes on disease in adults\nPneumococcal disease in persons with high-risk conditions\nPneumococcal vaccines in development\nCOVID effects on pneumonia and pneumococcal disease burden\nEffects of COVID on pneumoccoccal vaccine programmes\nManagement of community acquired pneumonia in the time of COVID\nEmerging data on SARS-CoV2 and pneumococcus interaction\n\nPlease visit the ISPPD-12 website for more information on how to participate.
URL:https://globalbiodefense.com/event/isppd-12-international-symposium-on-pneumococci-and-pneumococcal-diseases/
LOCATION:Sheraton Centre Toronto Hotel\, 123 Queen St W\, Toronto\, Ontario\, M5H 2M9
CATEGORIES:Conference
END:VEVENT
END:VCALENDAR